ライフサイエンスコーパス: thyroid disease

1 icians in the optimal surgical management of thyroid disease.

2 r autoimmune disorders, including autoimmune thyroid disease.

3 butes to the skin changes seen in autoimmune thyroid disease.

4 nd 18p11, showed association with autoimmune thyroid disease.

5 is a risk factor for developing symptomatic thyroid disease.

6 erapy, family cancer history, and history of thyroid disease.

7 bone mass, spine radiography, and history of thyroid disease.

8 AITD1, a susceptibility locus for autoimmune thyroid disease.

9 rtality occurs in both overt and subclinical thyroid disease.

10 lation between fetal cell microchimerism and thyroid disease.

11 people and in individuals with a history of thyroid disease.

12 many normal individuals without evidence of thyroid disease.

13 une disorders, notably juvenile diabetes and thyroid disease.

14 abetics and 377 clinic patients assessed for thyroid disease.

15 enal anomalies, hypertension, and autoimmune thyroid disease.

16 strategy to study PTC using a mouse model of thyroid disease.

17 failure, high-arched palate, and autoimmune thyroid disease.

18 TC1 in the peripheral blood of patients with thyroid disease.

19 toimmune adverse effects, such as autoimmune thyroid disease.

20 ounts were lower in patients with autoimmune thyroid disease.

21 alignancy, liver disease, kidney disease, or thyroid disease.

22 utoimmune Hashimoto's thyroiditis (HT) or no thyroid disease.

23 onary of RAI therapy in benign and malignant thyroid disease.

24 ve a high prevalence of benign and malignant thyroid disease.

25 berts first used radioactive iodine to treat thyroid disease.

26 ipants, and 386 control patients with benign thyroid disease.

27 associations between serum PBBs and PCBs and thyroid disease.

28 oid individuals as well as for patients with thyroid disease.

29 ation and edema in the setting of autoimmune thyroid disease.

30 c hypothyroidism, and 1.3% other/unspecified thyroid disease.

31 models) for a medically confirmed history of thyroid disease.

32 t was more common for neonates of women with thyroid disease.

33 tertiles, respectively) after adjusting for thyroid disease.

34 o best care for individuals with subclinical thyroid disease.

35 oduction, and reduces the risk of autoimmune thyroid disease.

36 for primary hypothyroidism, the most common thyroid disease.

37 patients with normal, benign, and malignant thyroid disease.

38 I for diagnostic and therapeutic purposes in thyroid diseases.

39 ases and were not restricted to inflammatory thyroid diseases.

40 ontrolling the initiation and progression of thyroid diseases.

41 n radioactive iodine was first used to treat thyroid diseases.

42 future therapeutics and risk prediction for thyroid diseases.

43 ders for improved noninvasive diagnostics of thyroid diseases.

44 hy, retinopathy of prematurity, and neonatal thyroid diseases.

45 t of 10,827 individuals screened for various thyroid diseases.

46 surement distinguished benign from malignant thyroid diseases.

47 Subject 2 developed autoimmune thyroid disease 1.6 years after transplantation.

48 ncrease in PBB-153 (0.43 ng/mL), the OR (any thyroid disease)=1.12; (95% CI: 0.83, 1.52) (n=105 cases

49 0 [4.4%]), diabetes mellitus (8 [1.7%]), and thyroid disease (8 [1.7%]).

50 hyroid group developed eye involvement after thyroid disease (80.0% in hypo vs. 48.1% in hyper, P = 0

51 32 (24.1%) of 133 patients were examined for thyroid disease after PET.

52 um thyrotropin levels rise as people without thyroid disease age; serum thyrotropin concentrations ma

53 Autoimmune thyroid disease (AITD) and pernicious anemia (PA) often

54 ariant also increased the risk of autoimmune thyroid disease (AITD) in the RA patients, whereas the F

55 Autoimmune thyroid disease (AITD) is a common autoimmune disease.

56 nal centers are often detected in autoimmune thyroid disease (AITD), but the mechanisms underlying ly

57 Autoimmune thyroid disease (AITD), including Graves' disease (GD) a

58 s of ankylosing spondylitis (AS), autoimmune thyroid disease (AITD), multiple sclerosis (MS) and brea

59 natures conferred a high risk for autoimmune thyroid disease (AITD).

60 shown to be strongly linked with autoimmune thyroid disease (AITD).

61 q22 in 81 sib pairs affected with autoimmune thyroid disease (AITD).

62 etween type 1A diabetes (T1D) and autoimmune thyroid disease (AITD).

63 Autoimmune thyroid diseases (AITD) affect 2-5% of the population, w

64 Autoimmune thyroid diseases (AITD) arise from complex interactions

65 The autoimmune thyroid diseases (AITD), Graves' disease and chronic lym

66 ss II variant conferring risk for autoimmune thyroid diseases (AITD).

67 Autoimmune thyroid diseases (AITDs) are highly prevalent, affecting

68 The autoimmune thyroid diseases (AITDs) include two related disorders,

69 The autoimmune thyroid diseases (AITDs), comprising Graves disease (GD)

70 n melanoma, other cancers, lung/liver/kidney/thyroid disease, alcohol/drug use, income/education, hem

71 n addition to fungicides, in the etiology of thyroid disease among female spouses enrolled in the Agr

72 A diagnosis of thyroid disease among patients with uveitis and respecti

73 e of adverse health effects (e.g., liver and thyroid disease and cancer), and innovative approach met

74 ion test for patients who have no history of thyroid disease and have few or no signs or symptoms of

75 s is one of very few models where autoimmune thyroid disease and hypothyroidism develop in most mice

76 Thyroid disease and osteoporosis are common problems oft

77 r/Ho TED patients including sex, duration of thyroid disease and pattern of eye involvement.

78 MS patients had slightly higher rates of thyroid disease and pernicious anaemia than did controls

79 With this increasing interest in thyroid disease and pregnancy, a variety of important st

80 concurrent autoimmune diseases of autoimmune thyroid disease and SLE.

81 method for (131)I RAIU measurement in benign thyroid disease and suggests that reducing the administe

82 Patients with benign thyroid disease and thyroid cancer were treated to achie

83 dividuals with PBC have a high prevalence of thyroid disease and thyroid disease is reportedly more p

84 o support associations of PBBs and PCBs with thyroid disease and thyroid hormone levels.

85 To determine the association between thyroid disease and uveitis.

86 responsible for immune dysregulation in both thyroid disease and uveitis.

87 rinary medicine, particularly for diagnosing thyroid diseases and guiding corrective therapy.

88 ohepatitis; however, the association between thyroid diseases and hepatocellular carcinoma (HCC) in m

89 tment, but otherwise the association between thyroid diseases and neonatal morbidity is understudied.

90 were seen individually or in clusters in all thyroid diseases and were not restricted to inflammatory

91 plies to each autoimmune disease, autoimmune thyroid disease (and Graves' disease in particular) cont

92 pertension, elderly, systolic heart failure, thyroid disease), and CHA(2)DS(2)-VASc.

93 ity, osteoporosis, atlantoaxial instability, thyroid disease, and celiac disease.

94 current preterm delivery, including alcohol, thyroid disease, and depression.

95 r mice survive, but display marked dwarfism, thyroid disease, and female infertility.

96 Graves' disease (GD) is a common thyroid disease, and Graves ophthalmopathy(GO) is the mo

97 ease, inflammatory bowel disease, autoimmune thyroid disease, and juvenile rheumatoid arthritis.

98 n thrombosis, hepatitis C, renal impairment, thyroid disease, and liver disease from 2003 to 2013 was

99 TSHR is also a primary antigen in autoimmune thyroid disease, and some TSHR antibodies may activate t

100 ' disease, Hashimoto thyroiditis, autoimmune thyroid disease, and systemic lupus erythematosus (SLE).

101 vitamin D deficiency, female sex, substernal thyroid disease, and thyroid cancer, necessitating centr

102 A), systemic lupus erythematosus, autoimmune thyroid disease, and type 1 diabetes mellitus, all of wh

103 atitis C receiving IFNalpha develop clinical thyroid disease, and up to 40% were reported to develop

104 ancy in the setting of underlying autoimmune thyroid disease, and with the use of certain medications

105 matoid arthritis, celiac disease, autoimmune thyroid diseases, and type 1 diabetes.

106 mber of deaths was small, and the underlying thyroid disease appeared to play a role.

107 ltrasound-based screening programs to detect thyroid disease are advised for patients and family memb

108 nefits of detecting and treating subclinical thyroid disease are not well established.

109 s variation in populations without diagnosed thyroid disease are poorly understood.

110 The cardiovascular signs and symptoms of thyroid disease are some of the most profound and clinic

111 iefly (131)I, the effects of which on benign thyroid diseases are largely unknown.

112 utoimmune disorders, particularly autoimmune thyroid disease, are common.

113 ith uveitis as the main outcome variable and thyroid disease as the main predictor variable, while ad

114 e for the increased female susceptibility to thyroid disease, at least on activation of the PI3K path

115 dent diabetes mellitus (IDDM) and autoimmune thyroid disease (ATD), share genetic risk factors.

116 assay on serum from patients with autoimmune thyroid disease (ATD).

117 s (a) four members with both candidiasis and thyroid disease, (b) five members, including one pair of

118 provide a molecular basis for understanding thyroid disease based on mutations of IYD.

119 th conditions (including physician-diagnosed thyroid disease), behaviors, and demographics.

120 Thyroid disease, breast disease and granulomatosis lung

121 by individuals with PTC, melanoma, or benign thyroid disease, but not by unaffected individuals.

122 test abnormalities that do not reflect true thyroid disease, but rather are a manifestation of secon

123 The skin is commonly affected in thyroid diseases, but the mechanism for this association

124 volume plays a key role in the treatment of thyroid diseases by radioactive iodine 131I.

125 many late effects (eg, second malignancies, thyroid disease, cardiovascular disease, and altered rep

126 on TECs during development of an autoimmune thyroid disease characterized by TEC hyperproliferation

127 mented water develop a slow onset autoimmune thyroid disease, characterized by thyrocyte epithelial c

128 re a prominent feature of the two autoimmune thyroid diseases, chronic lymphocytic (Hashimoto's) thyr

129 Accumulating evidence documents thyroid disease coexisting with connective tissue disord

130 study period, 29 (12.9%) had a diagnosis of thyroid disease, compared with 62 of 896 patients (6.9%)

131 type 1 diabetes mellitus and with autoimmune thyroid disease, confirming the findings of other invest

132 Moreover, thyroid disease could be accelerated in young NODCCR7(ko

133 Graves' disease (GD) is an autoimmune thyroid disease defined by the production of stimulating

134 rlipidemia, gastroesophageal reflux disease, thyroid disease, diabetes, osteoporosis) in the 12 month

135 d activity (clinical activity score) of TED, thyroid disease duration, TED duration and clinical sign

136 in thyroid function and the consequences of thyroid disease during pregnancy has rapidly grown in th

137 Subclinical thyroid disease during pregnancy may be associated with

138 ticipants increases the risk of the forms of thyroid disease evaluated in this study.

139 ze molecular/functional aspects of different thyroid diseases, even before clinical symptoms become m

140 ion, diabetes (type 1, type 2, gestational), thyroid disease, exercise, and BMI (HR, 0.73; 95% CI, 0.

141 otyped 77 affected sib-pairs with autoimmune thyroid disease for eight polymorphic markers spanning t

142 ergone lateral neck dissection for malignant thyroid disease from June 1, 2011, to June 30, 2021, and

143 e known significant geographic variations of thyroid disease, generalizability of these findings is u

144 curate and informative websites dedicated to thyroid disease, given the large number of patients who

145 of 115,746 participants without a history of thyroid disease, >/=20 years of age, was recruited in Ta

146 i population control group, patients who had thyroid disease had a 1.7-fold (95% CI, 1.03-2.80; P = .

147 d from a database if they had no preexisting thyroid disease, had taken amiodarone for >/=6 months, a

148 These findings suggest that a history of thyroid disease has a weak to moderate association with

149 ect of environmental radioiodine exposure on thyroid disease has been well studied, little is known r

150 Surgical management of thyroid disease has evolved considerably over several de

151 Familial clustering of autoimmune thyroid diseases has led to studies of their association

152 s (T1D), multiple sclerosis (MS), autoimmune thyroid disease (Hashimoto thyroiditis or Graves disease

153 7]), coeliac disease (28.4 [25.2-32.0]), and thyroid disease (Hashimoto's thyroiditis 13.3 [11.8-14.9

154 and 3 months included clinical measurements, thyroid disease history, and photographs.

155 dverse outcomes were chronic kidney disease, thyroid disease, hypercalcemia, weight gain, hypertensio

156 uch as sarcoidosis, endocrinopathies such as thyroid disease, immobilization, genetic disorders, and

157 id conditions included autoimmune diagnoses (thyroid disease in 14.6%, diabetes mellitus in 11.1%, in

158 eased risks of rare and common neoplasms and thyroid disease in adults and children.

159 ariation; penetrance of malignant tumors and thyroid disease in carriers of germline DICER1 variation

160 vance: Early identification and treatment of thyroid disease in children and adolescents is critical

161 There were 21 cases of thyroid disease in men [OR=0.69 (95% CI: 0.33); 1.44 for

162 They also assessed risk of thyroid disease in relation to ever use of herbicides, i

163 and associated with hypothyroidism and other thyroid disease in South Asians.

164 iation between fetal cell microchimerism and thyroid disease in women.

165 timation and received an HTDS evaluation for thyroid disease, including a thyroid ultrasound, physica

166 , the TSH polygenic score is associated with thyroid disease, including thyroid cancer and age-of-ons

167 thyroid disease, iodine allergy, recent ocular surgery,

168 h of the evidence that untreated subclinical thyroid disease is associated with clinical symptoms and

169 Thyroid disease is common, and evidence of an associatio

170 Thyroid disease is common, and thyroidectomy is a mainst

171 e Study (HTDS) was conducted to determine if thyroid disease is increased among persons exposed as ch

172 ociation between organochlorine exposure and thyroid disease is increasing.

173 The prevalence of unsuspected thyroid disease is lowest in men and highest in older wo

174 Thyroid disease is more common in women than men, and po

175 It is well known that thyroid disease is more frequent in women than in men; h

176 ave a high prevalence of thyroid disease and thyroid disease is reportedly more prevalent near Superf

177 ent in fibroblasts from donors without known thyroid disease, is partially susceptible to neutralizat

178 inations of generalized vitiligo, autoimmune thyroid disease, latent autoimmune diabetes in adults, r

179 se nationwide data suggest a need for better thyroid disease management to reduce neonatal morbidity.

180 disorders: type 1 diabetes mellitus (n = 4), thyroid disease (n = 2), and vitiligo (n = 2).

181 d hormones were measured in a subset without thyroid disease (n=551).

182 These associations frequently include thyroid disease, neutrophilic dermatoses, polyarthritis,

183 Neither concomitant nonsurgical thyroid disease nor more stringent selection criteria (p

184 ortance of the recognition of the effects of thyroid disease on the heart also derives from the obser

185 candidiasis only, and (c) three members with thyroid disease only.

186 FT4 (free thyroxine) and gait, without known thyroid disease or dementia.

187 icles that examined only patients with known thyroid disease or focused on accuracy of novel adjuncts

188 8), arthritis (OR, 1.44; 95% CI, 1.12-1.85), thyroid disease (OR, 1.43; 95% CI, 1.02-1.99), antihista

189 specially Sjogren's syndrome (P = 0.001) and thyroid disease (P = 0.012).

190 disease had a higher likelihood of previous thyroid disease, particularly either Graves' disease or

191 ial diagnoses, risks of progression to overt thyroid disease, potential effects on various health out

192 form of RP3, when expressed in patients with thyroid disease, presents an unusual altered self target

193 2p for chronic mucocutaneous candidiasis and thyroid disease, previously identified using a panel of

194 were those that included patients with known thyroid disease, prior thyroid ultrasonography, nodules

195 rthritis, polymyalgia rheumatica, autoimmune thyroid disease, psoriasis, and all others.

196 es were searched for articles on subclinical thyroid disease published between 1995 and 2002.

197 9) and without type 2 diabetes, uncontrolled thyroid disease, recent weight loss, or pregnancy.

198 have indicated that patients with autoimmune thyroid disease recognize epitopes of Tg which are not u

199 atients were recruited from 8 hospital-based thyroid-disease referral centers in Italy between 2006 a

200 e rate, 2.7 [CI, 1.3 to 5.0]) and history of thyroid disease (relative rate, 1.7 [CI, 1.1 to 2.6]) we

201 The risk of thyroid disease resulting from prolonged environmental 1

202 er autoimmune diseases, including autoimmune thyroid disease, rheumatoid arthritis, and type I diabet

203 f the skin, nails, and mucous membranes) and thyroid disease segregate as an autosomal dominant trait

204 The consequences of subclinical thyroid disease (serum TSH 0.1-0.45 mIU/L or 4.5-10.0 mI

205 Clinically relevant thyroid disease should be assessed preoperatively and ma

206 Screening for autoimmune thyroid disease should be performed.

207 ; and inclusion of heterogenous and changing thyroid disease states.

208 The Hanford Thyroid Disease Study (HTDS) was conducted to determine

209 Subclinical thyroid diseases--subclinical hyperthyroidism and subcli

210 important in order to avoid complications of thyroid disease such as cardiac arrhythmias.

211 nsion, coronary artery disease, uncontrolled thyroid disease, systemic inflammatory disease, diabetes

212 sk Force issued a guideline on screening for thyroid disease that included a systematic evidence revi

213 (cohorts 1 and 3) with documented autoimmune thyroid disease, the T allele frequency was higher than

214 These studies concern screening for thyroid disease, thyroid eye disease and treatment with

215 ch as inflammatory bowel disease, autoimmune thyroid disease, type 1 diabetes mellitus (T1D), and aut

216 nto either organ-specific illnesses, such as thyroid disease, type 1 diabetes, and mysasthenia gravis

217 comorbidities were hypertension, cataracts, thyroid disease, type 2 diabetes, and glaucoma.

218 o reduce the number of patients with nodular thyroid disease undergoing this invasive procedure.

219 diabetes mellitus type 1, rheumatic disease, thyroid disease, vitiligo, alopecia areata and inflammat

220 ia, systemic lupus erythematosus, autoimmune thyroid disease, vitiligo, and myasthenia gravis.

221 alence of self-reported clinically diagnosed thyroid disease was 12.5%, and prevalence of hypothyroid

222 ring 2005-2006, and information on diagnosed thyroid disease was collected by questionnaire.

223 Thyroid disease was common (18% overall; 25% among women

224 w-onset progressive proptosis although their thyroid disease was controlled and computed tomography s

225 Thyroid disease was determined based on International Cl

226 e 52.9% (18/34, P = .004) female; underlying thyroid disease was distributed between hyperthyroidism

227 The duration of thyroid disease was longer in Ho-TED (P = 0.002) while t

228 12,504 subjects for whom personal history of thyroid diseases was known.

229 Clinical findings related to thyroid disease were analyzed for those patients who com

230 women, all odds ratios (ORs) for PBB-153 and thyroid disease were positive for quintiles above the re

231 es for the care of the pregnant patient with thyroid disease were released by the Endocrine Society i

232 The data of 37 patients with benign thyroid diseases were assessed.

233 In conclusion, thyroid diseases were associated with increased neonatal

234 itis compared with patients who did not have thyroid disease when controlling for age, sex, race, smo

235 id not undergo any further investigation for thyroid disease, whereas 32 (24.1%) of 133 patients were

236 ble in the peripheral blood of patients with thyroid disease, which correlates with a diagnosis of ca

237 Incidences of thyroid disease, which has long been hypothesized to be

238 ients 65 years of age or older with no known thyroid disease who were recruited from primary care reg

239 Most persons found to have subclinical thyroid disease will have TSH values between 0.1 and 0.4

240 lowing lateral neck dissection for malignant thyroid disease with a short hospital stay has not been

241 rge home after neck dissection for malignant thyroid disease with a short hospital stay.

242 ignificance of the association of autoimmune thyroid disease with DTC is less clear.

243 assay methods, the association of autoimmune thyroid disease with DTC, the prognostic significance of

244 Data supporting associations of subclinical thyroid disease with symptoms or adverse clinical outcom

245 imaging and therapy of benign and malignant thyroid disease, worldwide.